{"id":18,"date":"2016-05-04T14:08:37","date_gmt":"2016-05-04T18:08:37","guid":{"rendered":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/?page_id=18"},"modified":"2017-05-16T15:04:31","modified_gmt":"2017-05-16T19:04:31","slug":"project","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/kenya\/project\/","title":{"rendered":"Objectives"},"content":{"rendered":"<p><strong>Primary objectives of the evaluation:<\/strong><\/p>\n<p><em>At the facility-level, to measure:<\/em><\/p>\n<ol>\n<li>Availability of NCD medicines at public and private non-profit facilities<\/li>\n<li>Price of NCD medicines at public private non-profit facilities<\/li>\n<li>Availability and price of NCD medicines at alternative for-profit drug sellers<\/li>\n<\/ol>\n<p><em>At the household-level, to measure:<\/em><\/p>\n<ol start=\"4\">\n<li>Availability of NCD medicines at households with NCD patients<\/li>\n<li>Price per unit paid for NCD medicines at households with NCD patients<\/li>\n<li>Expenditure on NCD medicines at households with NCD patients in relation to household wealth<\/li>\n<\/ol>\n<hr \/>\n<p><strong>Secondary objectives of the evaluation:<\/strong><\/p>\n<p><em>At the facility-level, to measure:<\/em><\/p>\n<ol>\n<li>Provider behavior diagnosing and prescribing NCD medicines<\/li>\n<\/ol>\n<p><em>At the household-level, to measure:<\/em><\/p>\n<ol start=\"2\">\n<li>Awareness of NCD medicines in households with NCD patients<\/li>\n<\/ol>\n<p><a title=\"Study Documents\" href=\"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/kenya\/study-documents\/\">Explore the protocol and study instruments<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Primary objectives of the evaluation: At the facility-level, to measure: Availability of NCD medicines at public and private non-profit facilities Price of NCD medicines at public private non-profit facilities Availability and price of NCD medicines at alternative for-profit drug sellers At the household-level, to measure: Availability of NCD medicines at households with NCD patients Price [&hellip;]<\/p>\n","protected":false},"author":11867,"featured_media":0,"parent":20,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/pages\/18"}],"collection":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/users\/11867"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/comments?post=18"}],"version-history":[{"count":20,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/pages\/18\/revisions"}],"predecessor-version":[{"id":448,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/pages\/18\/revisions\/448"}],"up":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/pages\/20"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-novartisaccess\/wp-json\/wp\/v2\/media?parent=18"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}